Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant Pneumococci

GAR-936, a new glycylcycline, had lower MICs (≤0.016 to 0.125 μg/ml) for 201 penicillin- and tetracycline-susceptible and -resistant pneumococcal strains than tetracycline (≤0.06 to 128 μg/ml), minocycline (≤0.06 to 16.0 μg/ml), or doxycycline (≤0.06 to 32.0 μg/ml). GAR-936 was also bactericidal aga...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hoellman, Dianne B., Pankuch, Glenn A., Jacobs, Michael R., Appelbaum, Peter C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89820/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10722519/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.4.1085-1088.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!